A clip from Episode 439 of the Relentless Health Value podcast. The conversation with Luke Slindee explores various solutions to drug pricing , such as the removal of "Usual and Customary Prices" from PBM contracts, the advantages of bypassing insurance, and giving patients direct payment tools like health savings accounts.
Related Videos
Primary Care is an Investment If It's Good Primary Care, Everything Else Is a Cost.
Here's a clip from Ep 467 or Relentless Health Value titled "Connecting Sky-High ER Spend to Primary Care Access—Follow the Dollar Through Carriers & Hospitals". === LINKS === 🎤 Listen to the full episode: https://youtu.be/yahgSNTwEiU 🔗 Show Notes with all mentioned links: https://cc-lnk.com/EP467...
Medicare Advantage Scandal: Denying and Delaying Needed Care in the #healthcareindustry
In this clip from Encore episode 384, we discuss a 2022 federal investigation which is relevant today which revealed that Medicare Advantage plans frequently deny and delay necessary care. A notable industry statistic highlights that 65% of denied prior authorizations are not appealed, shedding ligh...
Stacey Richter Discusses The Paradox of Being 'Functionally Uninsured'. #healthcareindustry
Navigating Moral Hazard and High-Value Care in Benefit Design This clip from the Relentless Health Value podcast 'Inbetweenisode', Stacey Richter delves into the complexities of moral hazard in the context of health insurance and benefit design. She discusses the significant impact of financial ince...